Is It Just for a Screening Program to Give People All the Information They Want?
- PMID: 37171853
- DOI: 10.1080/15265161.2023.2207510
Is It Just for a Screening Program to Give People All the Information They Want?
Abstract
Genomic screening at population scale generates many ethical considerations. One is the normative role that people's preferences should play in determining access to genomic information in screening contexts, particularly information that falls beyond the scope of screening. We expect both that people will express a preference to receive such results and that there will be interest from the professional community in providing them. In this paper, we consider this issue in relation to the just and equitable design of population screening programs like reproductive genetic carrier screening (RGCS). Drawing on a pluralistic public health ethics perspective, we claim that generating and reporting information about genetic variants beyond the scope of the screening program usually lacks clinical, and perhaps personal, utility. There are both pragmatic and ethical reasons to restrict information provision to that which fits the stated purpose of the program.
Keywords: Population; public health; reproductive technologies.
Comment in
-
Disclosing Reproductive Genetic Carrier Status: What about the Donor?Am J Bioeth. 2023 Jul;23(7):126-128. doi: 10.1080/15265161.2023.2207544. Am J Bioeth. 2023. PMID: 37339291 No abstract available.
-
When Less is More: Lessons for Expanded Carrier Screening from Newborn Sequencing Research.Am J Bioeth. 2023 Jul;23(7):118-120. doi: 10.1080/15265161.2023.2210037. Am J Bioeth. 2023. PMID: 37339293 Free PMC article. No abstract available.
-
From Community-Based Carrier Programs to Opportunistic Carrier Screening: How the Objective of Carrier Screening Was Lost in Translation.Am J Bioeth. 2023 Jul;23(7):123-126. doi: 10.1080/15265161.2023.2207520. Am J Bioeth. 2023. PMID: 37339295 No abstract available.
-
Narrative Equity in Genomic Screening at the Population Level.Am J Bioeth. 2023 Jul;23(7):121-123. doi: 10.1080/15265161.2023.2207548. Am J Bioeth. 2023. PMID: 37339300 No abstract available.
-
Whose Genome? Which Genetics?Am J Bioeth. 2023 Jul;23(7):50-53. doi: 10.1080/15265161.2023.2207528. Am J Bioeth. 2023. PMID: 37339304 No abstract available.
-
Getting It Right: How Public Engagement Might (and Might Not) Help Us Determine What Is Equitable in Genomics and Precision Medicine.Am J Bioeth. 2023 Jul;23(7):5-8. doi: 10.1080/15265161.2023.2215154. Am J Bioeth. 2023. PMID: 37339317 No abstract available.
-
Innovating for a Just and Equitable Future in Genomic and Precision Medicine Research.Am J Bioeth. 2023 Jul;23(7):1-4. doi: 10.1080/15265161.2023.2215201. Am J Bioeth. 2023. PMID: 37353052 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical